(Q36166374)

12 August 2017

1 reference

title

Review article: angiogenesis soluble factors as liver disease markers (English)

1 reference

12 August 2017

1 reference

1 reference

Salcedo X

1

1 reference

12 August 2017

Medina J

2

1 reference

12 August 2017

Sanz-Cameno P

3

1 reference

12 August 2017

García-Buey L

4

1 reference

12 August 2017

Martín-Vilchez S

5

1 reference

12 August 2017

Moreno-Otero R

6

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Alimentary Pharmacology & Therapeutics

12 August 2017

published in

1 reference

12 August 2017

volume

22

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

23-30

1 reference

Mechanisms of angiogenesis and arteriogenesis

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Angiogenic factors in squamous cell carcinoma of the oral cavity: do they have prognostic relevance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Angiopoietin/tie-2 as mediators of angiogenesis: a role in congestive heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Mast cell contribution to angiogenesis related to tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Anti-angiogenic therapy: rationale, challenges and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

VEGFs, receptors and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

VEGF-receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non-mucinous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Analysis of the role of chemokines in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02532.X

10.1111/J.1365-2036.2005.02532.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference